Creative Biolabs-Lipid Based Drug Delivery

Phosphatidylethanolamine (PE)

Phosphatidylethanolamine is one of the most abundant phospholipids in biological membranes, and due to its unique properties, it has received more and more attention in the pharmaceutical field in recent years. Thus, Creative Biolabs is committed to continuously providing more and better phospholipid-based pharmaceutical preparation services for its customers around the world, assisting them in achieving their strategic goals.

Background of Phosphatidylethanolamine

Phosphatidylethanolamine (PE) is a phospholipid found in all living organisms. Together with phosphatidylcholine (PC), phosphatidylserine (PS) and phosphatidylinositol (PI), PE represents the backbone of most biological membranes. PE is the second-most abundant phospholipid in mammalian membranes ranging from 20 to 50%. In healthy cells, PE resides predominantly in the inner leaflet of the cell membrane. In dead or dying cells, it’s externalized to the outer leaflet of the plasma membrane.

In mammalian cells, the biosynthesis of PE occurs mainly through two major pathways: by the decarboxylation of PS, which takes place at the mitochondrial membrane via phosphatidylserine decarboxylase (Psd) 1, or at the Golgi and vacuolar membranes through Psd2, and by the cytosine diphosphate (CDP)-ethanolamine pathway or Kennedy pathway at the endoplasmic reticulum (ER) membrane. Besides, the cells may employ other less quantitative synthetic routes, such as acylation of lyso-PE, and PS synthase-2-catalysis, as well as the base-exchange reaction between PS and ethanolamine. The relative contributions of the different PE biosynthetic pathways have been suggested to be dependent on the cell type.

The Structure and Function of Phosphatidylethanolamine

PE has a variety of physiological and biochemical functions, including but not limited to, chaperoning membrane proteins to their folded state; stimulating OXPHOS activity; attaching covalently to the autophagy protein Atg8, which initiates autophagosome formation; catalyzing the conversion of prions from the nontoxic to the toxic conformation; being an essential substrate for the synthesis of GPI-AP; being a precursor of other lipids; and it is associated with ER stress involving diabetes and neurodegeneration. More shockingly, PE with an arachidonic acyl chain is a target of lipoxygenase, which oxidizes an unsaturated acyl chain into a cytotoxic lipid hydroperoxide to facilitate ferroptosis. In addition, PE is a target of plant natural products that have potent anti-cancer activity, and the mitochondrial protein LACTB is a tumor suppressor that targets PSD for degradation.

Fig.1 The Structure of the Phosphatidylethanolamine. (Creative Biolabs Original) Fig 1 The Structure of the Phosphatidylethanolamine.

With years of experience and high-end technologies, Creative Biolabs provides our clients with products and custom services to help you get a milestone development in your drug delivery project. If you need help with this, please feel free to contact us.

For Research Use Only. Not For Clinical Use

Supports

Formulation Science Background of Liposome Research Highlights
Resources Technical Supports Featured Services Knowledge Center
Optimizing LNP Molar Ratios for Transfection Efficiency
Scalability Challenges in mRNA-LNP Manufacturing
Beyond mRNA: LNP Delivery for CRISPR/Cas9
Cationic Lipids Evolution: DOTAP to Ionizable Lipids
LNP Storage Stability: Lyophilization vs. Liquid
Modulating LNP Biodistribution: Overcoming Liver Accumulation
Active vs. Passive Targeting (EPR): A Guide to Tumor Drug Delivery
Immunoliposomes: Comparing Pre-insertion vs. Post-insertion Techniques
Crossing the BBB: Advances in Transferrin and Peptide-Modified Liposomes
pH-Responsive Liposomes for Tumor Microenvironment
Thermosensitive Liposomes combined with HIFU
Aptamer-Modified Liposomes: A Cost-Effective Antibody Alternative
Ethosomes vs Transfersomes for Dermal Delivery
Strategies for Encapsulating Poorly Water-Soluble Small Molecules in Liposomes
Multivesicular Liposomes: The Architecture of Sustained Release
Mechanisms of Liposomal Adjuvants in Enhancing Vaccine Immune Response
Protecting Enzymatic Activity: Liposomal Encapsulation Strategies for Enzymes
Cryo-TEM vs. DLS: Interpreting Discrepancies in Liposome Particle Size Data
Validating In Vitro Release Methods: Dialysis vs. Sample Separation Techniques
Predicting Long-Term Stability of Liposomal Suspensions using Zeta Potential
Troubleshooting Low Liposome Encapsulation Efficiency
Application of Multi-omics Analysis in Liposome Toxicology Assessment
The Ultimate Guide to Liposome Preparation
Fluorescent Liposomes for Cellular Uptake: Labeling, Controls, and Troubleshooting
How to Design Stealth Liposomes for Long Circulation
Homemade vs. Commercial Kits: Why Standardization Matters in Liposome Research

Online Inquiry